EU project starts work on world's largest dyslexia databank

A new EU-funded project is aiming to create the world's largest databank on dyslexia. Dyslexia is a common learning disorder that affects at least 5% of school children in Europe. The range and severity of the problem varies widely, but the main areas of difficulty are reading, writing, spelling, numeracy, personal organisation and time-keeping. The degree to which individuals may be affected ranges from mild spelling difficulties to severe organisational problems or complete illiteracy.

"Dyslexia is a huge societal problem, affecting one out of five children in Europe," says Franck Ramus of the French National Centre for Scientific Research (CNRS). "Although not as widespread compared to other diseases, it presents a major handicap to those that suffer from it."

CNRS is one of 13 partnering organisations from nine European countries involved in NEURODYS, a project funded under the "Life sciences, genomics and biotechnology for health" section of the Sixth Framework Programme (FP6). The purpose is to determine the biological and environmental factors involved in the disease.

"There's been a lot of research on dyslexia over the last 30 years, mainly on a cognitive and brain basis," told Dr Ramus. Neurological research suggests dyslexia is caused by some abnormality in the function of the left side of the brain which controls the lexical system, whereas cognitive research in recent years has increasingly focused on problems of phonological awareness - the awareness of the speech sounds within words. This has led to some speculation that these problems may be associated with a specific area of the brain. However, much of the research has been inconclusive.

"The NEURODYS project will also study dyslexia from the cognitive and brain basis but the main emphasis will be on its genetic basis," said Dr Ramus. "Although there has been some preliminary work done on dyslexia in the field of genetics, it was only with the mapping of the human genome in 2003, that real molecular studies on dyslexia could start." Specifically, the project will explore the links between the underlying active brain regions and risk-conferring genes.

One of the challenges of conducting a pan-European genetics study on dyslexia is the exceptionally large dataset required. Over a three-year period, the project aims to collect samples from a total of 4,000 children, coming from different countries across Europe to allow researchers to take into account language and environmental specificities.

A total of 2,000 samples have been collected so far and work has begun to develop a database. "This will be the world's largest databank," said Dr Ramus, who expects to see it get even bigger in the months to come. "There is mounting interest by US research groups to merge with us and create a transatlantic project on dyslexia."

By integrating new data at the molecular, cerebral and behavioural levels from across the different countries, the project partners expect to gain a deeper insight into which aspects of dyslexia are universal, and which are specific to each language. It will also enable scientists to establish a solid basis for improving diagnosis and treatment.

For further information, please visit:

  • http://www.neurodys.com
  • http://cordis.europa.eu/lifescihealth/home.html

    Copyright ©European Communities, 2006
    Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg – http://cordis.europa.eu.int. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI, Health, and Health Care Today and To…

Artificial intelligence (AI) carries promise and uncertainty for clinicians, patients, and health systems. This JAMA Summit Report presents expert perspectives on the opportunities, risks, and challenges of AI in health...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...

Improved Cough-Detection Tech can Help w…

Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making it easier to monitor chronic health conditions and predict health risks such...

New AI Tool Makes Medical Imaging Proces…

When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is...